146 related articles for article (PubMed ID: 11154238)
1. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.
Boussiotis VA; Chen ZM; Zeller JC; Murphy WJ; Berezovskaya A; Narula S; Roncarolo MG; Blazar BR
Blood; 2001 Jan; 97(2):565-71. PubMed ID: 11154238
[TBL] [Abstract][Full Text] [Related]
2. IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function.
Chen ZM; O'Shaughnessy MJ; Gramaglia I; Panoskaltsis-Mortari A; Murphy WJ; Narula S; Roncarolo MG; Blazar BR
Blood; 2003 Jun; 101(12):5076-83. PubMed ID: 12609834
[TBL] [Abstract][Full Text] [Related]
3. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.
Appleman LJ; Berezovskaya A; Grass I; Boussiotis VA
J Immunol; 2000 Jan; 164(1):144-51. PubMed ID: 10605005
[TBL] [Abstract][Full Text] [Related]
4. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
Salojin KV; Zhang J; Delovitch TL
J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678
[TBL] [Abstract][Full Text] [Related]
5. T cell hyporesponsiveness induced by oral administration of ovalbumin is associated with impaired NFAT nuclear translocation and p27kip1 degradation.
Asai K; Hachimura S; Kimura M; Toraya T; Yamashita M; Nakayama T; Kaminogawa S
J Immunol; 2002 Nov; 169(9):4723-31. PubMed ID: 12391180
[TBL] [Abstract][Full Text] [Related]
6. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
7. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H
J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680
[TBL] [Abstract][Full Text] [Related]
8. In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.
Lupino E; Buccinnà B; Ramondetti C; Lomartire A; De Marco G; Ricotti E; Tovo PA; Rinaudo MT; Piccinini M
Immunology; 2010 Oct; 131(2):231-41. PubMed ID: 20465575
[TBL] [Abstract][Full Text] [Related]
9. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA
J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta.
Zeller JC; Panoskaltsis-Mortari A; Murphy WJ; Ruscetti FW; Narula S; Roncarolo MG; Blazar BR
J Immunol; 1999 Oct; 163(7):3684-91. PubMed ID: 10490963
[TBL] [Abstract][Full Text] [Related]
12. Potent control of acute graft-versus-host disease lethality after immunization with a novel DNA vaccine targeted to B7-1/CD28 costimulatory signaling pathway.
Luo Y; Liang F; Liu N; Xue H; Song X; Yuan F; Long J; Zhao X; Sun Y; Xi Y
J Immunother; 2013 Feb; 36(2):82-92. PubMed ID: 23377669
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
[TBL] [Abstract][Full Text] [Related]
14. Soluble MHC-II proteins promote suppressive activity in CD4+ T cells.
Bakela K; Kountourakis N; Aivaliotis M; Athanassakis I
Immunology; 2015 Jan; 144(1):158-69. PubMed ID: 25053509
[TBL] [Abstract][Full Text] [Related]
15. Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells.
Janardhan SV; Praveen K; Marks R; Gajewski TF
PLoS One; 2011; 6(9):e24931. PubMed ID: 21949793
[TBL] [Abstract][Full Text] [Related]
16. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir I; Polyak K; Iavarone A; Massagué J
Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cells.
Schönle A; Hartl FA; Mentzel J; Nöltner T; Rauch KS; Prestipino A; Wohlfeil SA; Apostolova P; Hechinger AK; Melchinger W; Fehrenbach K; Guadamillas MC; Follo M; Prinz G; Ruess AK; Pfeifer D; del Pozo MA; Schmitt-Graeff A; Duyster J; Hippen KI; Blazar BR; Schachtrup K; Minguet S; Zeiser R
Blood; 2016 Apr; 127(15):1930-9. PubMed ID: 26837700
[TBL] [Abstract][Full Text] [Related]
18. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
19. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling.
Semple K; Nguyen A; Yu Y; Wang H; Anasetti C; Yu XZ
Blood; 2011 Mar; 117(11):3096-103. PubMed ID: 21245484
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
